|
Market Closed -
NSE India S.E.
09:07:19 22/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 405.55 INR | +6.89% |
|
+7.08% | +360.07% |
Company Valuation: Ind-Swift Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,251 | 3,938 | 3,262 | 5,918 | 4,961 | 11,397 |
| Change | - | -7.37% | -17.18% | 81.43% | -16.17% | 129.72% |
| Enterprise Value (EV) 1 | 14,189 | 13,254 | 11,701 | 1,764 | 695.5 | 7,184 |
| Change | - | -6.59% | -11.72% | -84.92% | -60.59% | 932.99% |
| P/E | -135x | -183x | 6.85x | 1.41x | 2.38x | 26.1x |
| PBR | 0.7x | 0.66x | 0.48x | 0.64x | 0.49x | 0.82x |
| PEG | - | 5.8x | -0x | 0x | -0x | -0.3x |
| Capitalization / Revenue | 0.47x | 0.37x | 0.27x | 0.46x | 0.88x | 1.76x |
| EV / Revenue | 1.56x | 1.26x | 0.96x | 0.14x | 0.12x | 1.11x |
| EV / EBITDA | 8.54x | 5.96x | 4.9x | 0.66x | -3.19x | 16.1x |
| EV / EBIT | 12.8x | 14.3x | 6.45x | 0.82x | -1.59x | 43.9x |
| EV / FCF | 58x | 49.3x | 26.6x | 0.18x | -0.33x | -5.29x |
| FCF Yield | 1.72% | 2.03% | 3.76% | 558% | -302% | -18.9% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.5326 | -0.3637 | 8.055 | 71.24 | 35.21 | 5.03 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 9,068 | 10,521 | 12,159 | 12,973 | 5,617 | 6,491 |
| EBITDA 1 | 1,661 | 2,224 | 2,389 | 2,683 | -217.8 | 445.2 |
| EBIT 1 | 1,110 | 924.1 | 1,815 | 2,150 | -438.6 | 163.7 |
| Net income 1 | -31.47 | -21.49 | 476 | 4,210 | 2,505 | 431.2 |
| Net Debt 1 | 9,938 | 9,315 | 8,439 | -4,153 | -4,265 | -4,212 |
| Reference price 2 | 71.95 | 66.65 | 55.20 | 100.15 | 83.96 | 131.43 |
| Nbr of stocks (in thousands) | 59,087 | 59,087 | 59,087 | 59,087 | 59,087 | 86,712 |
| Announcement Date | 7/9/21 | 7/9/22 | 5/9/23 | 6/9/24 | 5/9/25 | 5/9/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 344M | |
| 34.48x | 6.47x | 22.44x | 0.91% | 46.81B | |
| 15.9x | 1.97x | 8.74x | 1.7% | 37.1B | |
| 27.84x | 3.97x | 16.45x | 0.58% | 12.09B | |
| 26.98x | 3.27x | 16.95x | 0.94% | 11.69B | |
| 18.58x | 3.37x | 11.75x | 3.79% | 9.03B | |
| 9.49x | 2.2x | 5.69x | 4.68% | 7.45B | |
| 29.8x | 3.9x | 18.14x | 0.16% | 7.22B | |
| 15.18x | 2.01x | 6.67x | 3.28% | 7.13B | |
| Average | 22.28x | 3.39x | 13.35x | 2% | 15.43B | |
| Weighted average by Cap. | 24.67x | 3.98x | 15.15x | 1.57% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- INDSWFTLAB Stock
- Valuation Ind-Swift Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
